Login to Your Account



JV approved: Hutchison Whampoa Sinopharm Pharmaceuticals emerges

By Cornelia Zou
Staff Writer

Wednesday, April 23, 2014

HONG KONG – Hutchison China Meditech Ltd. (LSE:HCM) and Sinopharm Group Co. Ltd. (SEHK:1099) have gained regulatory approval for their new joint venture that will provide sales, distribution and marketing services to pharmaceutical companies in China.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription